Thomas Weisel Upgrades Medicis Pharmaceutical (MRX); Bernstein Downgrades MRX
More News related to MRX
- Medicis to Present at Piper Jaffray Annual Health Care Conference
- Piper Jaffray Upgrades Medicis Pharmaceutical (MRX) to Neutral; Gaining More Confidence
- Medicis to Present at Credit Suisse Annual Healthcare Conference
- Medicis (MRX) Reports Q3 EPS of $0.50, Beats by 8c; Guides Q4
- Medicis Reports Third Quarter 2009 Financial Results
Thomas Weisel upgrades Medicis Pharmaceutical (NYSE: MRX) from Marketweight to Overweight.
However, Bernstein downgrades MRX from Outperform to Market Perform.
To see more analyst ratings on MRX Click Here.
Medicis Pharmaceutical Corporation operates as a specialty pharmaceutical company in the United States and Canada.
Related Categories
DowngradesUpgrades
Stocks Mentioned
-0.59Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
